Sade Spencer1, Daniela Neuhofer2, Vivian C Chioma2, Constanza Garcia-Keller2, Danielle J Schwartz2, Nicholas Allen2, Michael D Scofield3, Tara Ortiz-Ithier4, Peter W Kalivas2. 1. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina. Electronic address: spencers@umn.edu. 2. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina. 3. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina; Department of Anesthesiology, Medical University of South Carolina, Charleston, South Carolina. 4. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina; Department of Physiology, University of Puerto Rico, Rio Piedras, Puerto Rico.
Abstract
BACKGROUND: Cannabis is the most widely used illicit drug, but knowledge of the neurological consequences of cannabis use is deficient. Two primary components of cannabis are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). We established a THC+CBD model of self-administration and reinstated drug seeking to determine if, similar to other addictive drugs, cannabis produces enduring synaptic changes in nucleus accumbens core (NAcore) thought to contribute vulnerability to drug reinstatement. METHODS: Sprague Dawley rats were trained to self-administer THC+CBD (n = 165) or were used as vehicle self-administering control animals (n = 24). Reinstatement was initiated by context, cues, drug priming, and stress (yohimbine injection). Enduring neuroadaptations produced by THC+CBD self-administration were assayed using four measures: dendritic spine morphology, long-term depression, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/N-methyl-D-aspartate ratios, and behavioral pharmacology. RESULTS: We described a novel rodent model of cannabis relapse involving intravenous THC+CBD self-administration and drug seeking induced by conditioned context, cues, and stress. Cued reinstatement of THC+CBD seeking depended on a sequence of events implicated in relapse to other addictive drugs, as reinstatement was prevented by daily treatment with N-acetylcysteine or acute intra-NAcore pretreatment with a neuronal nitric oxide synthase or matrix metalloprotease-9 inhibitor, all of which normalize impaired glutamate homeostasis. The capacity to induce N-methyl-D-aspartate long-term depression in NAcore medium spiny neurons was abolished and dendritic spine density was reduced, but alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/N-methyl-D-aspartate ratio was unaltered in THC+CBD-trained animals, akin to opioids, but not to psychostimulants. CONCLUSIONS: We report enduring consequences of THC+CBD use on critical relapse circuitry and synaptic physiology in NAcore following rat self-administration and provide the first report of cue- and stress-induced reinstatement with this model.
BACKGROUND: Cannabis is the most widely used illicit drug, but knowledge of the neurological consequences of cannabis use is deficient. Two primary components of cannabis are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). We established a THC+CBD model of self-administration and reinstated drug seeking to determine if, similar to other addictive drugs, cannabis produces enduring synaptic changes in nucleus accumbens core (NAcore) thought to contribute vulnerability to drug reinstatement. METHODS:Sprague Dawley rats were trained to self-administer THC+CBD (n = 165) or were used as vehicle self-administering control animals (n = 24). Reinstatement was initiated by context, cues, drug priming, and stress (yohimbine injection). Enduring neuroadaptations produced by THC+CBD self-administration were assayed using four measures: dendritic spine morphology, long-term depression, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/N-methyl-D-aspartateratios, and behavioral pharmacology. RESULTS: We described a novel rodent model of cannabis relapse involving intravenous THC+CBD self-administration and drug seeking induced by conditioned context, cues, and stress. Cued reinstatement of THC+CBD seeking depended on a sequence of events implicated in relapse to other addictive drugs, as reinstatement was prevented by daily treatment with N-acetylcysteine or acute intra-NAcore pretreatment with a neuronal nitric oxide synthase or matrix metalloprotease-9 inhibitor, all of which normalize impaired glutamate homeostasis. The capacity to induce N-methyl-D-aspartate long-term depression in NAcore medium spiny neurons was abolished and dendritic spine density was reduced, but alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/N-methyl-D-aspartateratio was unaltered in THC+CBD-trained animals, akin to opioids, but not to psychostimulants. CONCLUSIONS: We report enduring consequences of THC+CBD use on critical relapse circuitry and synaptic physiology in NAcore following rat self-administration and provide the first report of cue- and stress-induced reinstatement with this model.
Authors: David A Baker; Krista McFarland; Russell W Lake; Hui Shen; Xing-Chun Tang; Shigenobu Toda; Peter W Kalivas Journal: Nat Neurosci Date: 2003-07 Impact factor: 24.884
Authors: Cassandra D Gipson; Kathryn J Reissner; Yonatan M Kupchik; Alexander C W Smith; Neringa Stankeviciute; Megan E Hensley-Simon; Peter W Kalivas Journal: Proc Natl Acad Sci U S A Date: 2013-05-13 Impact factor: 11.205
Authors: Shelby L Blaes; Caitlin A Orsini; Hannah M Holik; Toneisha D Stubbs; Shandera N Ferguson; Sara C Heshmati; Matthew M Bruner; Shannon C Wall; Marcelo Febo; Adriaan W Bruijnzeel; Jennifer L Bizon; Barry Setlow Journal: Neurobiol Learn Mem Date: 2018-12-03 Impact factor: 2.877
Authors: Daniela Neuhofer; Sade M Spencer; Vivian C Chioma; Lauren N Beloate; Danielle Schwartz; Peter W Kalivas Journal: Addict Biol Date: 2019-11-16 Impact factor: 4.280
Authors: Angeline J Dukes; James P Fowler; Valeria Lallai; Anna N Pushkin; Christie D Fowler Journal: Nicotine Tob Res Date: 2020-07-16 Impact factor: 4.244
Authors: Cora E Smiley; Heyam K Saleh; Katherine E Nimchuk; Constanza Garcia-Keller; Justin T Gass Journal: Behav Brain Res Date: 2021-08-10 Impact factor: 3.352
Authors: Devan M Gomez; Thomas J Everett; Lindsey R Hamilton; Ajit Ranganath; Joseph F Cheer; Erik B Oleson Journal: Neuropharmacology Date: 2020-10-25 Impact factor: 5.250